Anti-Adhesion Products Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

Global Anti-adhesion Products Market: Snapshot

The global anti-adhesion products market is foreseen to collect strong growth prospects while riding on the growing occurrence of postsurgical adhesive diseases and their clinical ramifications and unwanted patient outcomes. The solid focus on the reduction of direct healthcare expenditure for the treatment of adhesion-related complications and hospital admissions could be a positive factor augmenting the demand in the market. Rising awareness about the medical implications of adhesions among both patients and physicians is anticipated to set the tone for a worthwhile growth of the market. Furthermore, factors such as the high volume growth of surgical procedures and demographic trends could supplement market growth in the foreseeable future.

The need for advanced adhesion barrier solutions is increasing as a result of more than a 250 million surgical procedures conducted on an annual basis globally. Although North America is prognosticated to lead the global anti-adhesion products market, Asia Pacific could exhibit a faster growth on account of growing medical tourism, increasing affordability for surgical intervention care, rising in per capita healthcare spending, increasing affluence, and developing healthcare infrastructure.

On a global platform, the market for anti-adhesion products could see a rise due to the swelling prevalence of carpal tunnel syndrome and cardiovascular diseases. After performing cardiac surgeries, there is often the need to prevent retrosternal pericardial and sternum adhesions. More opportunities are expected to take shape in the global anti-adhesion products market with the rise of reconstructive pelvic surgeries among women. The need to ensure safer surgical recoveries and the replacement of conventional products with improved ones could enhance the growth of the demand in the market. All of these factors are prognosticated to bring in ample of prospects in the coming years and increase the expectations of players in terms of market share.

Adhesion is one of the common problems affecting almost 55% to 90% patients followed by surgery. Adhesion is a band of scar tissue formed between organs and tissue after a surgery as a part of a normal healing process. However, when it connects wrong tissues into each other, adhesions may lead to severe clinical symptoms such as pelvic pain, intestinal blockage, infertility and loss of sensation depending on the location and size of the adhesions.  Adhesions are most common after surgeries such as abdominal surgery, thoracic surgery, gynaecological surgery and plastic surgery. After abdominal surgery, bowels and pelvic organs may adhere with each other as a result of adhesion causing risks for small bowel obstruction and severe pain. The various types of adhesions based on their locations are abdominal adhesions, intestinal adhesions, intraperitoneal adhesions and pelvic adhesions.

 

Some of the anti-adhesion products available in the market are Adept (Baxter), Seprafilm (Genzyme), INTERSEED (Johnson & Johnson) and Surgiwrap (MAST Biosurgery). The market for anti-adhesion products can be segmented on the basis of types of surgery such as abdominal surgery, gynecological surgery and other surgical procedures. The market for anti-adhesion products is growing due to large number incidences of adhesion associated with various surgeries. Usually 55% to 90% patients undergoing abdominal and gynecological surgeries face adhesion problems. Presently, North America represents the largest market as a number of products have been approved by FDA. Asia-Pacific is experiencing growth as large number of patients are undergoing abdominal and gynecological surgeries. In the coming future the market will witness growth with the introduction of new products with more efficacy.

 

Some of the major vendors operating in this market are Johnson & Johnson, Baxter International, WL Gore, Anika Therapeutics, Inc., Angiotech Pharmaceuticals, Inc., Genzyme Corporation, LifeCell Corporation and MAST Biosurgery AG.

 

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include 

• North America 
• Asia Pacific 
• Europe
• Rest of the World  

• Market growth drivers 
• Factors limiting market growth
• Current market trends 
• Market structure
• Market projections for upcoming years 

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis. 

 

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth 
• It provides a technological growth map over time to understand the industry growth rate
• It provides a seven-year forecast assessed on the basis of how the market is predicted to grow 
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments 
• It provides distinctive graphics and exemplified SWOT analysis of major market segments